Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2015

Open Access 01-12-2015 | Poster presentation

Multidrug resistant bacterial isolates causing nosocomial urinary tract infection in a tertiary care hospital, Nepal

Author: MK Sah

Published in: Antimicrobial Resistance & Infection Control | Special Issue 1/2015

Login to get access

Excerpt

Nosocomial infection is becoming a leading problem in medical practitioners now-a-days placing an extra burden on individual patients worldwide. Nosocomial urinary tract infection caused by multidrug resistant (MDR) pathogens is a major threat of the patients in developing country which are increasing numbers in Nepal. …
Metadata
Title
Multidrug resistant bacterial isolates causing nosocomial urinary tract infection in a tertiary care hospital, Nepal
Author
MK Sah
Publication date
01-12-2015
Publisher
BioMed Central
DOI
https://doi.org/10.1186/2047-2994-4-S1-P222

Other articles of this Special Issue 1/2015

Antimicrobial Resistance & Infection Control 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine